Search Results
Dec 02, 2025, 10:33 ET HeroX Facilitates NIH Common Fund's Advancement of Human-Based Research with New Validation Challenge
Participants will advance promising NAMs, including microphysiological systems, computational models, and other human-biology-centered approaches, through rigorous testing and qualification processes.Traditional research models remain valuable in many contexts, but NAMs offer unique advantages for understanding
More news about: HeroX
Dec 02, 2025, 06:00 ET bit.bio Publishes 2025 Sustainability Report
testing and accelerate the use of New Approach Methodologies (NAMs). New UK policy commitments to phase out specific animal tests, together with the US Food and Drug Administration's roadmap to replace parts of preclinical safety testing with NAMs signal a global shift towards models based on human cells,
More news about: bit.bio
Dec 02, 2025, 06:00 ET bit.bio Publishes 2025 Sustainability Report
testing and accelerate the use of New Approach Methodologies (NAMs). New UK policy commitments to phase out specific animal tests, together with the US Food and Drug Administration's roadmap to replace parts of preclinical safety testing with NAMs signal a global shift towards models based on human cells,
More news about: bit.bio
Nov 20, 2025, 15:05 ET RIFM Announces Its 4th Annual Science Symposium: From Research to Real-World
Safety Discover RIFM's leadership in environmental protection through updated frameworks, New Approach Methodologies (NAMs), and robust ecological risk assessment aimed at supporting long-term planetary health. Track 3: Science
More news about: Research Institute for Fragrance Materials
Nov 18, 2025, 07:00 ET Integral Consulting and ScitoVation Deepen Strategic Partnership, Develop Faster Chemical Safety Decisions, Using Advanced Molecular and Computational Toxicology Tools
ScitoVation announce successful deployment of molecular and computational toxicology tools that use artificial intelligence and new approach methodologies (NAMs) to speed chemical safety assessments and make fuller use of emerging data streams.
More news about: Integral Consulting Inc.
Nov 13, 2025, 08:54 ET G. Frank Gerberick, PhD, Honored with 2025 Robert H. Bedoukian Excellence in Science Award
collaborates closely with RIFM, lending his expertise to ongoing research in skin sensitization, respiratory allergy, and New Approach Methodologies (NAMs) for photoallergy. Known for his calm, methodical approach and generosity as a mentor, he has inspired countless researchers and advanced the next generation
More news about: Research Institute for Fragrance Materials
Oct 30, 2025, 08:49 ET Bespoke Concierge MD Expands Women's Health Services with New Comprehensive Assessment Program
in eight U.S. women will develop breast cancer in her lifetime (American Cancer Society), while about 1.3 million women enter menopause each year (NIH/NAMS). Yet fewer than 25 percent receive accurate counseling or treatment, even though hormone therapy remains the most effective option for many.
More news about: Bespoke Concierge MD
Oct 16, 2025, 05:00 ET Peptilogics Raises $78 Million to Advance Zaloganan Into Pivotal Trial
technologies. These investors have backed paradigm-shifting companies including AbCellera (ABCL), Atai Life Sciences (ATAI), New Amsterdam Pharma (NAMS), Compass Pathways (CMPS), Kriya Therapeutics, and F2G. This group combines deep domain expertise with a shared commitment to advancing breakthroughs
More news about: Peptilogics
Oct 14, 2025, 07:00 ET Caristo Chosen by Leading Pharma Company as Worldwide Imaging Core Lab to Measure Coronary Plaque and Inflammation
The REMBRANDT trial, sponsored by NewAmsterdam Pharma (Nasdaq: NAMS), is a placebo-controlled, double-blind, randomized trial designed to assess the efficacy of obicetrapib and ezetimibe fixed dose combination (FDC) on
More news about: Caristo Diagnostics
Oct 10, 2025, 08:48 ET Development of the First Inner Ear Organoids by 3D Bioprinting for Pharmacological Screening in Hearing Disorders: CTIBIOTECH™ Announces Strategic Agreement With SATT AxLR and CILCARE
bio-extrusion additive manufacturing and automation technologies to inner ear organoids. CTIBIOTECH™, by facilitating a highly advanced non-animal NAMs (New Approach Methods) alternative in the hearing disorders sector, strengthens its position at the forefront of a cell-based bioassay
More news about: CTIBIOTECH, CILCARE and SATT AXLR
Sep 29, 2025, 06:35 ET Expert Systems Inc., a leading drug discovery accelerator, proudly announces the Series A funding and launch of Mondego Bio, an emerging immuno-oncology company headquartered at Biocant Park in Cantanhede, Portugal.
Tudor Oprea, CEO of Expert Systems Inc. "By integrating predictive ADMET and PK/PD modeling with in-silico and in vitro new-approach methodologies (NAMs), we gave Mondego Bio a decisive edge — identifying high-potential PTPN2 inhibitors and accelerating their journey into development.."
More news about: Expert Systems, Inc.
Sep 23, 2025, 08:48 ET World's First Computer-connected Lab Grown Human Bioprinted Skin: CTISKIN™ by CTIBIOTECH™ Sweeps Awards at IFSCC 2025 Congress with Groundbreaking Bioprinted Skin Technology
connected to a computer for instantaneous and highly accurate product evaluations. This advancement is part of New approach methodologies (NAMs) and promises to significantly reduce the reliance on animal testing, enhance the speed and efficacy of product development, and provide unprecedented
More news about: CTIBIOTECH
Sep 16, 2025, 16:32 ET 5G Is Powering the Modernization of Manufacturing in America
to leverage 5G's unprecedented speeds, low latency and high capacity to power new innovations—particularly through the use of AI. According to the NAM's Manufacturing Leadership Council's 2025 Future of Manufacturing Project Survey, "Shaping the AI-Powered Factory of the Future," more than half of manufacturers
More news about: CTIA